Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pandox in connection with a directed share issue
Assignment

Vinge has advised Pandox in connection with a directed share issue

March 30, 2017

Vinge has advised Pandox Aktiebolag (publ) in connection with a directed share issue of 7,499,99 class B shares at a subscription price of SEK 135 per share. Through the share issue, Pandox will obtain approximately SEK 1,012 million. The subscription price was determined through an accelerated book-building process. The share issue is directed to selected Swedish and international institutional investors. The purpose of the share issue is to, in a timely and cost efficient manner, enable a capital raising to finance acquisitions and thereby increase the company’s financial flexibility and mandate for continued value creation.
 
Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. The company’s shares are admitted to trading on Nasdaq Stockholm.
 
Vinge’s team primarily consisted of Jesper Schönbeck, Erik Sjöman, Nils Fredrik Dehlin, Tora Hansjons and Michaela Cronemyr.

Related

Vinge advises Zellis Group, a portfolio company of Apax Partners, in connection with the acquisition of Benify

 Vinge has, together with Kirkland & Ellis, advised Zellis Group, a portfolio companya of funds advised by Apax Partners LLP (“Apax”), in connection with the acquisition of Benify, a provider of employee benefits administration software, from Vitruvian Partners and the other shareholders.
September 09, 2024

Vinge advises Blue Wolf Capital Partners in connection with the acquisition of seven manufacturing and development facilities from Recipharm

 Vinge has, together with Kirkland & Ellis, advised Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the healthcare and industrial sectors, in connection with the acquisition of seven manufacturing and development facilities in Sweden, France, and Spain, from Recipharm Group, a contract development and manufacturing organization (“CDMO”) headquartered in Stockholm.
September 03, 2024

Vinge advises on the sale of Märta Måås-Fjetterström’s business

 Vinge has advised the Swedrup family in connection with the sale of Märta Måås-Fjetterström, Verkstaden för svenska mattor och vävnader Aktiebolag. The company manufactures rugs and tapestries in Båstad based on designs by both Märta Måås-Fjetterström herself and her successors, such as Barbro Nilsson, Marianne Richter, Ann-Mari Forsberg and others. The buyer is the Hult family.
September 03, 2024